ArticleLeukemia2022
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome.
Peng Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it